Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
Clinical trial NCT06779097 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06779097
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2027-03-01
- Enrollment
- 1564
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.